Peptide record

TPDB07507

Antibacterial Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07507
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 Peptipedia
standard
No
A 14-aa standard-residue multi-activity (Antibacterial and Toxicity) peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
LLRRVAGLLKQFAK
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C75H133N23O16
NDCEHIMPSTWY
L
1613.03
12.42
4
0
8
+4
1.09
0.364
146.43
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
0
0.00
1
Residue Composition
number
2
A
2
R
0
N
0
D
0
C
0
E
1
Q
1
G
0
H
0
I
4
L
2
K
0
M
1
F
0
P
0
S
0
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 2 R: 2 N: 0 D: 0 C: 0 E: 0 Q: 1 G: 1 H: 0 I: 0 L: 4 K: 2 M: 0 F: 1 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 1
Chemical Descriptors
14 reviewed residue count
C75H133N23O16 sequence-only estimate (linear, free termini)
1613.03 sequence-only estimate (linear, free termini)
12.42 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
1.09 sequence-only estimate (linear, free termini)
0.364 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Activity

<5% Hemolysis
Toxicity
256 µg/mL
Hemolytic Cytotoxic
<5% Hemolysis | 256 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Prokaryotic expression and antimicrobial mechanism of XPF-St7-derived ?-helical peptides. | J Pept Sci | 2015